Orismilast for the Treatment of Mild to Severe Hidradenitis Suppurativa

NCT04982432 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Hidradenitis Suppurativa

Interventions

DRUG: Orismilast

Sponsor

Gregor Jemec

Collaborators

[object Object]